Wednesday, July 26, 2017

Analysts on Novavax stock slide: 'The path forward did not meet expectations'

Analysts explain Wall Street’s unfavorable reaction to the Gaithersburg biotech’s new plan for its RSV vaccine candidate for the elderly.



from https://www.bizjournals.com/baltimore/news/2017/07/26/analysts-on-novavax-stock-slide-the-path-forward.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/163444299707

No comments:

Post a Comment